Skip to content

Clinical trials

Completed Myeloproliferative Disorders trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Status: Completed Country / region: New Zealand Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group1
National Cancer Institute (NCI)1
Sierra Oncology LLC - a GSK company1
The Canadian Blood and Marrow Transplant Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders4
Leukemia, Myelomonocytic, Chronic3
Primary Myelofibrosis3
Anemia, Refractory2
Anemia, Refractory, with Excess of Blasts2
Leukemia2
Myelodysplastic Syndromes2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Anemia1
Blast Crisis1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.